A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Essen Biotech
Second Life Therapeutics
Hadassah Medical Organization
Sensei Biotherapeutics, Inc.
Kineta Inc.
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
Novartis
National Institutes of Health Clinical Center (CC)
N.N. Petrov National Medical Research Center of Oncology
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Mirror Biologics, Inc.
Fred Hutchinson Cancer Center